Influence of vancomycin on renal function in critically ill patients after cardiac surgery: Continuous versus intermittent infusion

Anesthesiology

Volumn 111, Issue 2, 2009, Pages 356-365

  Hutschala, Doris ^a   Kinstner, Christian ^a   Skhirdladze, Keso ^a   Thalhammer, Florian ^a   Müller, Markus ^a   Tschernko, Edda ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG INTERMITTENT THERAPY; ELECTIVE SURGERY; FEMALE; GRAM POSITIVE INFECTION; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEPHROTOXICITY; OPEN HEART SURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 68249135304     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181a97272     Document Type: Article

References (39)

1. Austin TW, Coles JC, Burnett R, Goldbach M: Aortocoronary bypass procedures and sternotomy infections: A study of antistaphylococcal prophylaxis. Can J Surg 1980; 23:483-5
2. Fong IW, Baker CB, McKee DC: The value of prophylactic antibiotics in aorta-coronary bypass operations. J Thorac Cardiovasc Surg 1979; 78:908-13
3. Knauss WA, Draper EA, Wagner DP, Zimmerman JE: Prognosis in acute organ system failure. Ann Surg 1985; 202:685-92
4. Zeckel ML: A closer look at vancomycin, teicoplanin and antimicrobial resistance. J Chemother 1997; 9:311-35
5. Del Mar Fernandez de Gatta Garcia M, Revilla N, Calvo MV, Dominguez-Gil A, Sanchez Navarro A: Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 2007; 33:279-85
6. Kato Y, Shime N, Hashimoto S, Nomura M, Okayama Y, Yamagishi M, Fujita N: Effects of controlled perioperative antimicrobial prophylaxis on infectious outcomes in pediatric cardiac surgery. Crit Care Med 2007; 35:1763-8
7. Duckworth GJ: Diagnosis and management of methicillin resistant Staphylococcus aureus infection. BMJ 1993; 307:1049-52
8. Duffull SB, Begg EJ, Chambers ST, Barclay ML: Efficacies of different vancomycin dosing regimes against Staphylococcus aureus determined with a dynamic in vitro model. Antimicrob Agents Chemother 1994; 38:2480-2
9. Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE: Linezolid versus glycopeptide or beta-lactam for treatment of grampositive bacterial infectins: Meta-analysis of randomised controlled trials. Lancet Inf Dis 2008; 8:53-66
10. Barraclough K, Harris M, Montessori V, Levin A: An unusual case of acute kidney injury due to vancomycin-lessons learnt from reliance on eGFR. Nephrology Dialysis Transplantation 2007; 22:2391-4
11. Malacarne P, Bergamasco S, Donadio C: Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients. Chemotherapy 2006; 52:178-84
12. Saunders NJ: Why monitor peak vancomycin concentrations? Lancet 1994; 344:1748-50
13. Kasiakou SK, Sermaides GJ, Michalopoulos A, Soteriades ES, Falagas ME: Continuous versus intermittent intravenous administration of antibiotics: A metaanalysis of randomised controlled trials. Lancet Infect Dis 2005; 5:581-9
14. Di Filippo A, De Gaudio AR, Novelli A: Continous infusion of vancomycin in methicillin-resistant staphylococcus infection. Chemotherapy 1998; 44:63-8
15. James JK, Palmer SM, Levine DP, Rybak MJ: Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob Agents Chemother 1996; 40:696-700
16. Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, Thomas F, Timist JF, Similowski T, Mentec H, Mier L, Dreyfuss D: Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study. Antimicrob Agents Chemother 2001; 45:2460-7
17. Klepser ME, Patel KB, Nicolau DP, Quintiliani R, Nightingale CH: Comparison of bactericidal activities of intermittent and continous infusion dosing of vancomycin against methicillin-resistant staphylococcus aureus and enterococcus faecalis. Pharmacotherapy 1998; 18:1069-74
18. Vuagnat A, Stern R, Lotthe A, Schuhmacher H, Duog M, Hoffmeyer P, Bernard L: High dose vancomycin for osteomyelitis: Continuous versus intermittent infusion. J Clin Pharm Ther 2004; 29:351-7
19. Byl B, Jacobs F, Wallemacq P, Rossi C, De Francquen PH, Cappello M, Leal T, Thys JP: Vancomycin penetration of unifected pleural fliud exudates after continuous or intermittent infusion. Antimicrob Agents Chemother 2003; 47:2015-7
20. Wysocki M, Thomas F, Wolff MA, Pean Y, Ravaud Y, Herman B: Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections. J Antimicrob Chemother 1995; 35:352-4
21. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephro 2004; 15:1597-605
22. Llopis-Salvia P, Jimenez-Torre NV: Population pharmacokinetic parameters of vancomycin in critically ill patients. J Clin Pharm Therap 2006; 31:447-54
23. Peake M, Whiting M: Measurement of serum creatinine-Current status and future goals. Clin Biochem Rev 2006; 27:174-84
24. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, and the Acute Kidney Injury Network: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Critical Care 2007; 11:R31
25. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-40
26. Matthews JN, Altman DG, Campbell MJ: Royston: Analysis of serial measurements in medical research. BMJ 1990; 300:230-5
27. Levine DP, Fromm BS, Reddy BR: Slow response to vancomycin or vancomycin plus rifampicin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991; 115:674-80
28. Cruciani M, Gatti G, Lazzarini L, Furian G, Broccali G, Malena M, Franchini C, Concia E: Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 1996; 38:865-9
29. Pea F, Viale P: Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin? Clin Pharmacokinet 2008; 47:147-52
30. Aeschlimann JR, Hershberger E, Rybak MJ: Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43:1914-8
31. Bagshaw SM, George C, Bellomo R, for the ANZICS Database Management Committee: A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23:1569-74
32. Lassnigg A, Schmid ER, Hiesmayr M, Falk Ch, Druml W, Bauer P, Schmidlin D: Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: Do we have to revise current definitions of acute renal failure? Crit Care Med 2008; 36:1129-37
33. Rondon-Berrios H, Palevsky PM: Treatment of acute kidney injury: An update on the management of renal replacement therapy. Curr Opin Nephrol Hypertens 2007; 16:64-70
34. Demirkiliç U, Kuralay E, Yenicesu M, Caǧlar K, Oz BS, Cingöz F, Günay C, Yildirim V, Ceylan S, Arslan M, Vural A, Tatar H: Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 2004; 19:17-20
35. Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R: Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007; 33:1285-96
36. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16:3046-52
37. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43:405-14
38. Sivagnanam S, Deleu D: Red man syndrome. Critical Care 2003; 7:119-20
39. Wazny DL, Behnam D: Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother 2001; 35:1458-64